George Washington (GW) Cancer Center Selected as First Global Site for Regeneron High Risk Cutaneous Cell Cancer

George Washington (GW) Cancer Center Selected as First Global Site for Regeneron High Risk Cutaneous Cell Cancer

The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous cell carcinoma. GW Cancer Center was selected for this Regeneron-sponsored Phase II...
Clinical Research as a Care Option in Baltimore Offered by The Sandra & Malcolm Berman Cancer Institute at GBMC

Clinical Research as a Care Option in Baltimore Offered by The Sandra & Malcolm Berman Cancer Institute at GBMC

The Sandra and Malcolm Berman Cancer Institute at GBMC, a multidisciplinary team, manages clinical trials in the effort to bring progressive clinical research as care options to cancer care. But many in the community don’t trust clinical research. Hence, there is a...

Pin It on Pinterest